Center at UCSF is pioneering the development of potent drug candidates aimed at preventing future coronavirus pandemics. Researchers at UC San Francisco and the Gladstone Institutes have developed new ...

The US administration should clear up the confusion over the future of a widely admired AIDS fund and push for Congress to ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

NanoViricides, Inc. (NYSE American: NNVC), (the "Company"), a leading clinical stage global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that ...

Dozens of trials on HIV ground to a halt in February after US President Donald Trump abruptly pulled crucial funding.

Viral proteases have often been the target of attempts to make antiviral drugs, most notably for HIV. Shoichet’s molecular ...

A team at UC San Francisco and Gladstone Institutes has developed new drug candidates that show great promise against the virus that causes COVID-19 and potentially other coronaviruses that could ...

With Washington state Gov. Bob Ferguson signing bills into law, critics of the overuse of emergency clauses in bills are ...

Today, antiviral medications can turn HIV, a once fatal infection, into a chronic condition. Nonetheless, the cocktail of pills remains out of reach for many—and lapses in the daily regimen ...

A team at UCSF and Gladstone Institutes developed new drug candidates that show great promise against the virus that causes ...

Thus, development of an antiviral drug against Measles must become a top ... seasonal Influenza, HIV, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others. NanoViricides' platform ...

An examination of recent litigation under the Employee Retirement Income Security Act of 1974 (ERISA) challenging allegedly ...